Robenacoxib
![]()  | |
| Clinical data | |
|---|---|
| Trade names | Onsior | 
| License data | |
| ATCvet code | |
| Legal status | |
| Legal status | 
  | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.210.035 | 
| Chemical and physical data | |
| Formula | C16H13F4NO2 | 
| Molar mass | 327.279 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
InChI 
  | |
Robenacoxib, sold under the brand name Onsior, is a nonsteroidal anti-inflammatory drug (NSAID) used in veterinary medicine for the relief of pain and inflammation in cats and dogs.[1][2] It is a COX-2 inhibitor (coxib).
References
- ↑ Gaynor JS, Muir WM (2014). "Robenacoxib". Handbook of Veterinary Pain Management (3rd, revised ed.). Elsevier Health Sciences. ISBN 9780323222143.
 - ↑ Clark-Price S (2014). "Nonsteroidal anti-inflammatory drugs and corticosteroids: Robenacoxib". In Egger CM, Love L, Doherty T (eds.). Pain management in veterinary practice. Ames, Iowa: Wiley-Blackwell. ISBN 9781118761601.
 
External links
- "Robenacoxib". Drug Information Portal. U.S. National Library of Medicine.
 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
